The Effect of COVID-19 Pandemic on Adolescent and Young Adult Cancer Patients and Survivors
Recruiting · NCT04551378 · Observational (researchers observe without assigning treatment) · Lead sponsor: M.D. Anderson Cancer Center
View the official record on ClinicalTrials.gov →Interventions studied
What this trial is about
The study investigates how the COVID-19 pandemic has impacted the psychological, financial, physical, and social well-being of adolescent and young adult (AYA) cancer patients and survivors. AYA cancer survivors have inferior long-term survival compared to the general population, and the negative impact of the global COVID-19 pandemic may be even higher in this vulnerable group. The information gained from this study may provide an opportunity to determine the self-reported COVID-19 specific psychological distress in AYA cancer survivors, and may lead to the development of a targeted intervention to improve physical and psychosocial health for AYA cancer patients and survivors.
Who can take part
Inclusion criteria
- PATIENT COHORT INCLUSION:
- Initial cancer diagnosis between the ages of 15 to 39
- Received any cancer treatment at MD Anderson Cancer Center with data available in the MD Anderson Cancer Center Tumor Registry
- For questionnaire provision: confirmed alive at time of contact
Exclusion criteria
- PATIENT COHORT EXCLUSION:
- Inability to complete questionnaires in English
- Seen at MD Anderson for a second opinion or non-treatment related visit
Where it is running
1 location listed across 1 US state.
- M D Anderson Cancer Center - Houston, Texas, United States